Accrued expenses consisted of the following (in thousands):
December 31,2024
December 31,2023
Accrued pre-clinical and clinical costs
$
2,424
1,449
Accrued product development costs
280
745
Accrued license costs
—
4,825
Accrued compensation
2,276
2,326
Accrued administrative costs
446
343
Accrued interest
1,342
Total
5,426
11,030
No definition available.
Tabular disclosure of the components of accrued liabilities.